Home
/
GOLDENWELL BIOTECH, INC.
/
Financials
/
Quarterly
GOLDENWELL BIOTECH, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that GOLDENWELL BIOTECH, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Dec 8, 2025
Q2
2025
Jun 30, 2025
$0
Sep 12, 2025
Q1
2025
Mar 31, 2025
$0
May 27, 2025
Q3
2025
Sep 30, 2024
$0
Dec 8, 2025
Q2
2025
Jun 30, 2024
$139
Sep 12, 2025
Q1
2025
Mar 31, 2024
$0
May 27, 2025
Q1
2021
Mar 31, 2021
$0
Aug 5, 2021
Q3
2020
Sep 30, 2020
$0
Feb 23, 2021
Q1
2021
Mar 31, 2020
$0
Aug 5, 2021
Q3
2020
Sep 30, 2019
$0
Feb 23, 2021
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$0
Nov 26, 2024
Q2
2024
Jun 30, 2024
$139
Aug 22, 2024
Q1
2024
Mar 31, 2024
$158
May 20, 2024
Q3
2024
Sep 30, 2023
$382
Nov 26, 2024
Q2
2024
Jun 30, 2023
$276
Aug 22, 2024
Q1
2024
Mar 31, 2023
$1.4K
May 20, 2024
Q3
2023
Sep 30, 2022
$43.7K
Nov 13, 2023
Q2
2023
Jun 30, 2022
$3.7K
Aug 17, 2023
Q1
2023
Mar 31, 2022
$397
May 19, 2023
Q3
2022
Sep 30, 2021
$12.2K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$1.1K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$0
May 18, 2022
Q3
2021
Sep 30, 2020
$0
Jan 3, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.0K)
Dec 8, 2025
Q2
2025
Jun 30, 2025
($5.2K)
Sep 12, 2025
Q3
2025
Jun 30, 2025
($5.2K)
Dec 8, 2025
Q1
2025
Mar 31, 2025
($34.4K)
May 27, 2025
Q3
2025
Mar 31, 2025
($34.4K)
Dec 8, 2025
Q3
2025
Sep 30, 2024
$23.1K
Dec 8, 2025
Q3
2025
Jun 30, 2024
$49.9K
Dec 8, 2025
Q2
2025
Jun 30, 2024
($49.9K)
Sep 12, 2025
Q2
2024
Mar 31, 2024
($31.0K)
Aug 22, 2024
Q1
2025
Mar 31, 2024
($31.1K)
May 27, 2025
Q3
2025
Mar 31, 2024
$31.0K
Dec 8, 2025
Q3
2024
Dec 31, 2023
($20.8K)
Nov 26, 2024
Q1
2024
Dec 31, 2023
($20.8K)
May 20, 2024
Q2
2024
Dec 31, 2023
($20.8K)
Aug 22, 2024
Q1
2024
Sep 30, 2023
($35.4K)
May 20, 2024
Q3
2024
Sep 30, 2023
($35.4K)
Nov 26, 2024
Q2
2024
Sep 30, 2023
($35.4K)
Aug 22, 2024
Q3
2023
Jun 30, 2023
($27.1K)
Nov 13, 2023
Q1
2024
Jun 30, 2023
($27.1K)
May 20, 2024
Q2
2024
Jun 30, 2023
($27.1K)
Aug 22, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.9K)
Dec 8, 2025
Q2
2025
Jun 30, 2025
($3.1K)
Sep 12, 2025
Q1
2025
Mar 31, 2025
($32.3K)
May 27, 2025
Q3
2025
Sep 30, 2024
($21.0K)
Dec 8, 2025
Q2
2025
Jun 30, 2024
($47.8K)
Sep 12, 2025
Q1
2025
Mar 31, 2024
($29.0K)
May 27, 2025
Q3
2024
Sep 30, 2023
($35.4K)
Nov 26, 2024
Q2
2024
Jun 30, 2023
($27.1K)
Aug 22, 2024
Q1
2024
Mar 31, 2023
($33.6K)
May 20, 2024
Q3
2023
Sep 30, 2022
($4.6K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($26.8K)
Aug 17, 2023
Q1
2023
Mar 31, 2022
($33.4K)
May 19, 2023
Q3
2022
Sep 30, 2021
($88.7K)
Nov 14, 2022